Press releases

March 28, 2023

Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

Read more

March 21, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

March 14, 2023

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Read more

February 28, 2023

Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference

Read more

February 16, 2023

Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

Read more

February 09, 2023

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update

Read more

January 06, 2023

Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones

Read more

January 04, 2023

Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference

Read more

December 21, 2022

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

November 22, 2022

Ultragenyx to Present at Piper Sandler Healthcare Conference

Read more